(PharmaNewsWire.Com, March 06, 2018 ) Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.
Regions Covered: -North America - US - Canada - Mexico -Europe - Germany - France - Italy - UK - Spain - Rest of Europe -Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific -Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
